Search alternatives:
significantly related » significantly correlated (Expand Search), significantly reduced (Expand Search), significantly greater (Expand Search)
related decrease » related disease (Expand Search), greater decrease (Expand Search), related diseases (Expand Search)
mean decrease » a decrease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
Showing 121 - 140 results of 38,060 for search '(( significantly related decrease ) OR ( significant ((gap decrease) OR (mean decrease)) ))', query time: 1.26s Refine Results
  1. 121
    Age-specific survival rate (<i>l</i><sub><i>x</i></sub>), fecundity (<i>m</i><sub><i>x</i></sub>), and maternity (<i>l</i><sub><i>x</i></sub><i>m</i><sub><i>x</i></sub>) of <i>A</i>. <i>glycines</i>.

    Age-specific survival rate (<i>l</i><sub><i>x</i></sub>), fecundity (<i>m</i><sub><i>x</i></sub>), and maternity (<i>l</i><sub><i>x</i></sub><i>m</i><sub><i>x</i></sub>) of <i>A</i... by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  2. 122
    Toxic effects of imidacloprid and thiamethoxam on the first instar nymphs of <i>A</i>. <i>glycines</i>.

    Toxic effects of imidacloprid and thiamethoxam on the first instar nymphs of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 123
    Age-specific survival rate (<i>l</i><sub><i>x</i></sub>), fecundity (<i>m</i><sub><i>x</i></sub>), and maternity (<i>l</i><sub><i>x</i></sub><i>m</i><sub><i>x</i></sub>) of <i>A</i>. <i>glycines</i>.

    Age-specific survival rate (<i>l</i><sub><i>x</i></sub>), fecundity (<i>m</i><sub><i>x</i></sub>), and maternity (<i>l</i><sub><i>x</i></sub><i>m</i><sub><i>x</i></sub>) of <i>A</i... by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 124
    Age-stage-specific survival rate (<i>s</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>.

    Age-stage-specific survival rate (<i>s</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 125
    Age-stage-specific reproductive values (<i>v</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>.

    Age-stage-specific reproductive values (<i>v</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 126
    Toxic effects of imidacloprid and thiamethoxam on the first instar nymphs of <i>A</i>. <i>glycines</i>.

    Toxic effects of imidacloprid and thiamethoxam on the first instar nymphs of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 127
    Life expectancy (<i>e</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>.

    Life expectancy (<i>e</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 128
    Life expectancy (<i>e</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>.

    Life expectancy (<i>e</i><sub><i>xj</i></sub>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 129
    Pre-exposure to mRNA-LNPs or LNPs significantly inhibits subsequent adaptive immune responses induced by the mRNA-LNP vaccine.

    Pre-exposure to mRNA-LNPs or LNPs significantly inhibits subsequent adaptive immune responses induced by the mRNA-LNP vaccine. by Zhen Qin (411748)

    Published 2022
    Save to List
    Saved in:
  10. 130
    AKI significantly affects the expression of various metabolites related to TRP catabolism.

    AKI significantly affects the expression of various metabolites related to TRP catabolism. by Einat Bigelman (5367932)

    Published 2023
    “…<p>(A-D) Box plot graphs showing the change of relative intensity in AKI-1d (n = 5) and AKI-1w (n = 4) versus the mean intensity value of the sham group (n = 5) per each metabolite. …”
    Save to List
    Saved in:
  11. 131
    Forest plots illustrate the mean difference in; (A) creatinine clearance, (B) eGFR, (C) BUN, and (D) shows relative risk in ARF.

    Forest plots illustrate the mean difference in; (A) creatinine clearance, (B) eGFR, (C) BUN, and (D) shows relative risk in ARF. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Save to List
    Saved in:
  12. 132
    Summary of PTI and WLI with repeated measurement (mean, 95% CI).

    Summary of PTI and WLI with repeated measurement (mean, 95% CI). by Guangquan An (11473126)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 133
    Bilateral network comparison of features (mean ± SD).

    Bilateral network comparison of features (mean ± SD). by Kang Wu (160544)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 134
    LAB decreased the TGF-β-induced HSCs-activation markers <i>in vitro</i>.

    LAB decreased the TGF-β-induced HSCs-activation markers <i>in vitro</i>. by Paulraj Kanmani (706306)

    Published 2022
    Save to List
    Saved in:
  15. 135
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 136
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 137
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 138
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 139
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 140
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:

Search Tools: